Research and Markets: 2015-2019 US Cancer Diagnostics Market - Competitive Landscape, Supplier Shares, Country Segment Forecasts, Innovative Technologies & Instrumentation Review

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/52pn2g/20152019_us) has announced the addition of the "2015-2019 US Cancer Diagnostics Market--Competitive Landscape, Supplier Shares, Country Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering.

2015-2019 US Cancer Diagnostics Market is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual cancer diagnostic test.

- Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment, including:

- Hospitals

- Commercial/Private Laboratories

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.

- Cancer statistics, etiology and recent developments.

Current and Emerging Products - Review of over 200 current and emerging cancer diagnostic tests, including:

- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Assessments

- Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

For more information visit http://www.researchandmarkets.com/research/52pn2g/20152019_us

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics